FiercePharmaAsia File Podcast: Benitec explains CEO shakeup, company's future

FiercePharmaAsia's Matt Driskill discusses the recent conference call held by Benitec Biopharma ($BNTC) in Australia in which interim CEO Greg West explains the rather abrupt departure of CEO Peter French and outlines the company's search for a replacement who can bring deep experience in the American market. Listen below.

 

 

 

 

Suggested Articles

The Shire bid Takeda’s been discussing is getting real. The Japanese drugmakers is gauging lender interest in financing the buy.

After initial doubts, some analysts now like Takeda's chances of pulling off a deal for embattled Shire.

Sanofi is out another potential buyer for its European generics business as India-based Torrent Pharma exited deal talks, according to a report.